Bleeding, thrombosis, and anticoagulation in myeloproliferative neoplasms (MPN): analysis from the German SAL-MPN-registry

Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera

(2015) Alessandro M. Vannucchi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prophylaxis and management of venous thromboembolism in patients with myeloproliferative neoplasms: consensus statement of the Haemostasis Working Party of the German Society of Hematology and Oncology (DGHO), the Austrian Society of Hematology and Oncology (ÖGHO) and Society of Thrombosis and Haemostasis Research (GTH e.V.)

(2014) Stephan Kreher et al.   ANNALS OF HEMATOLOGY

Molecular genetics of chronic neutrophilic leukemia, chronic myelomonocytic leukemia and atypical chronic myeloid leukemia

(2014) Bing Li et al.   Journal of Hematology & Oncology

Treatment of thromboembolic events coincident with the diagnosis of myeloproliferative neoplasms: A physician survey

(2014) Martin H. Ellis et al.   THROMBOSIS RESEARCH

JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes

(2013) E. Rumi et al.   BLOOD

Anagrelide compared with hydroxyurea in WHO-classified essential thrombocythemia: the ANAHYDRET Study, a randomized controlled trial

(2013) H. Gisslinger et al.   BLOOD

Myeloproliferative neoplasms and thrombosis

(2013) T. Barbui et al.   BLOOD

Inzidenz und Überleben bei Leukämien in Deutschland nach aktuellen standardisierten Kategorien

(2013) A. Nennecke et al.   Bundesgesundheitsblatt-Gesundheitsforschung-Gesundheitsschutz

Somatic CALR Mutations in Myeloproliferative Neoplasms with Nonmutated JAK2

(2013) J. Nangalia et al.   NEW ENGLAND JOURNAL OF MEDICINE

Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms

(2013) Thorsten Klampfl et al.   NEW ENGLAND JOURNAL OF MEDICINE

JAK2 Mutation-Related Disease and Thrombosis

(2013) Paola Guglielmelli et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS

Are MPNs Vascular Diseases?

(2013) Guido Finazzi et al.   Current Hematologic Malignancy Reports

Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk stratification, and management

(2012) Ayalew Tefferi   AMERICAN JOURNAL OF HEMATOLOGY

Dysfunction of the PI3 kinase/Rap1/integrin  IIb 3 pathway underlies ex vivo platelet hypoactivity in essential thrombocythemia

(2012) S. F. Moore et al.   BLOOD

Correlation of blood counts with vascular complications in essential thrombocythemia: analysis of the prospective PT1 cohort

(2012) P. J. Campbell et al.   BLOOD

Front-line therapy in polycythemia vera and essential thrombocythemia

(2012) Tiziano Barbui et al.   BLOOD REVIEWS

Patterns of Survival Among Patients With Myeloproliferative Neoplasms Diagnosed in Sweden From 1973 to 2008: A Population-Based Study

(2012) Malin Hultcrantz et al.   JOURNAL OF CLINICAL ONCOLOGY

Recurrent SETBP1 mutations in atypical chronic myeloid leukemia

(2012) Rocco Piazza et al.   NATURE GENETICS

Cardiovascular Events and Intensity of Treatment in Polycythemia Vera

(2012) Roberto Marchioli et al.   NEW ENGLAND JOURNAL OF MEDICINE

Management of Myeloproliferative Neoplasms: From Academic Guidelines to Clinical Practice

(2012) Giovanni Barosi et al.   Current Hematologic Malignancy Reports

TET2, ASXL1, IDH1, IDH2, and c-CBL genes in JAK2- and MPL-negative myeloproliferative neoplasms

(2011) Luz Martínez-Avilés et al.   ANNALS OF HEMATOLOGY

Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet

(2011) Tiziano Barbui et al.   JOURNAL OF CLINICAL ONCOLOGY

Long-term follow-up of patients with portal vein thrombosis and myeloproliferative neoplasms

(2011) J. HOEKSTRA et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Venous thromboembolism in patients with essential thrombocythemia and polycythemia vera

(2011) H Reikvam et al.   LEUKEMIA

Thrombosis in primary myelofibrosis: incidence and risk factors

(2009) T. Barbui et al.   BLOOD

The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases

(2008) J.-J. Kiladjian et al.   BLOOD

Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments

(2008) V. De Stefano et al.   HAEMATOLOGICA

Life expectancy and prognostic factors in the classic BCR/ABL-negative myeloproliferative disorders

(2008) F Cervantes et al.   LEUKEMIA